The article reports on the move of the Pharmaceutical Researchers and Manufacturers of America, PhRMA, to seek a curb to the growing public criticism over its consumer advertising practices by releasing voluntary advertising guidelines in the U.S. The document stated that drug advertising should serve the public health by increasing awareness about diseases and educating patients about treatment options.